← Back to Program
EvolutionFoundation
3

Capital & Value

Funding Pathways & Deal Mechanics

Overview

Every capital decision you make today determines what happens at exit. The valuation you accept, the terms you sign, the preferences you grant, and the governance provisions you overlook do not disappear after closing. They compound. This evolution teaches you how capital decisions shape your company’s structure, governance, and the amount of money that reaches the people who built it.

Format
Online
Items
37
Duration
8-12 hours
Recommended for
  • Pre-fundraise founders
  • Series A and B negotiations
  • Term sheet review preparation
  • Cap table and dilution modeling
  • Down round exposure
  • Exit waterfall analysis
THE LEARNING FRAMEWORK

The learning framework

1

The healthcare innovators who celebrated the wrong number

A healthcare innovator closes a Series B at a $120 million valuation. The press release goes out. The team celebrates. Two years later, an acquirer offers $150 million. The innovator expects a significant payout. Then the waterfall runs. Liquidation preferences consume $80 million. Participation rights take another $20 million. The innovator, who held 28% of the company, receives less than 10% of the exit price. The valuation was never the number that mattered. The terms were.

2

Why healthcare innovators confuse valuation with value

Healthcare innovators are trained to evaluate evidence, assess risk, and make decisions under uncertainty. None of that training addresses how venture financing actually works. They sign term sheets without modeling how liquidation preferences behave at different exit prices. They accept participation rights without understanding the double-dip. They negotiate valuation while ignoring the provisions that determine who gets paid, in what order, and how much. Each decision is made once, under time pressure, and each one compounds into the cap table that governs every future round and the exit itself.

3

Capital decisions made with structural literacy

Healthcare innovators who complete this evolution do not enter a financing round without understanding what every clause costs them at exit. They model dilution across rounds. They calculate the preference stack before they sign. They distinguish between capital sources that align with their timeline and those that create governance and exit constraints. The difference between the innovator who captures value and the one who gives it away is not the exit multiple. It is whether they understood the deal mechanics before or after they signed.

WHAT YOU WILL LEARN

By the end of this evolution, you will be able to:

Map where your venture sits in the value creation cycle

Place your company on the seven-stage lifecycle from idea through exit. Identify the capital decisions that correspond to your current stage and the structural consequences of getting them wrong.

Distinguish the two products every innovator sells

Understand that you sell both a customer product and an investment security. Learn why these require different skills, different narratives, and different metrics, and why conflating them is one of the most common fundraising mistakes.

Model dilution across multiple rounds

Calculate how founder ownership changes from incorporation through seed, option pool creation, Series A, and beyond. Run exit waterfalls that show the dollar gap between expected and actual proceeds.

Read a term sheet the way an investor reads it

Analyze the 29 provisions in a standard NVCA term sheet. Understand how each feeds the payout machine, the control machine, or the employment machine, and which provisions cost you the most at exit.

Calculate what liquidation preferences and participation rights actually cost

Run the math on 1x vs. 2x preferences, non-participating vs. full participating, and stacked seniority. See how the same exit price produces dramatically different founder payouts depending on terms.

Evaluate capital sources for structural fit

Compare angels, family offices, venture capital, growth equity, sovereign wealth, and strategic investors. Understand what each expects, how they operate post-investment, and where the alignment and conflict points are for your specific venture.

WHY THIS MATTERS

Why this matters

Valuation is the number everyone celebrates. Structure is the system that determines what that number actually means at exit. This evolution shifts your attention from the headline to the provisions that control proceeds distribution.

Most innovators treat the cap table as a record of ownership. It is actually a structural map of who gets paid, who controls decisions, and who has leverage in the next negotiation. Reading it correctly changes every capital conversation.

Investors ask five questions they never say out loud. They evaluate your security, not your product. This evolution teaches you what they are actually assessing and how to prepare for it before the conversation begins.

Liquidation preferences, participation rights, anti-dilution protections, and seniority stacking are not exit-day decisions. They are financing-round decisions that compound across the life of the company. Understanding them before you sign is the entire point.

Recommended for

Healthcare innovators navigating:

First institutional fundraise
Term sheet negotiation and review
Cap table modeling and dilution analysis
Liquidation preference and waterfall calculations
Down round preparation and anti-dilution exposure
Investor source evaluation and alignment
Exit proceeds forecasting
Bridge financing and convertible note structuring
HOW TO GET STARTED

How to get started

Your path to becoming a Certified Professional Entrepreneur

1st Step

Submit your Application

Apply online. Our team reviews your clinical, research, or entrepreneurial background to confirm this certification aligns with your professional trajectory.

2nd Step

Join the AEIOU community

Once accepted, you gain access to our network of healthcare innovators, researchers, and operators who have navigated the decisions you are preparing for.

3rd Step

Begin your first evolution

Start inside the AEIOU learning portal with structured content, scenario drills, working tools, and case studies drawn from real transactions.

EXPAND YOUR KNOWLEDGE

Continue your structural training

Answers that help you decide with confidence

Need help?

Get in touch with us

Contact Us

The terms you sign today determine the payout you receive at exit.

Know what every clause costs before you sign it.

Book your career pathway call
Next cohort begins soon
Next Cohort begins June 17, 2026